Lipid profile and inflammatory markers associated with estrogen receptor α PvuII and XbaI gene polymorphisms

Translational Research

Volumn 153, Issue 6, 2009, Pages 288-295

  Boroumand, Mohammadali ^a   Ghaedi, Mahboubeh ^b   Mohammadtaghvaei, Narges ^b   Pourgholi, Leila ^a   Anvari, Maryam Sotoudeh ^a   Davoodi, Gholamreza ^a   Amirzadegan, Alireza ^a   Saadat, Soheil ^c   Sheikhfathollahi, Mahmood ^d   Goodarzynejad, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRIEDEWALD FORMULA; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFLAMMATION; IRAN; LIPID ANALYSIS; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PVUII GENE; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XBAL GENE;

EID: 65549094948     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.02.006     Document Type: Article

References (33)

1. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 75 (2001) 898-915
2. Knopp R.H., and Zhu X. Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab 82 (1997) 3952-3954
3. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
4. Hsia J., Criqui M.H., Herrington D.M., et al. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J 152 (2006) 170-176
5. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534
6. Hodis H.N., Mack W.J., Azen S.P., et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 349 (2003) 535-545
7. Maas A.H., van der Schouw Y.T., Grobbee D.E., and van der Graaf Y. Rise and fall of hormone therapy in postmenopausal women with cardiovascular disease. Menopause 11 (2004) 228-235
8. Hopkins P.N., and Brinton E.A. Estrogen receptor 1 variants and coronary artery disease: shedding light into a murky pool. JAMA 290 (2003) 2317-2319
9. Vongpatanasin W., Tuncel M., Wang Z., Arbique D., Mehrad B., and Jialal I. Differential effects of oral versus transdermal estrogen replacement therapy on CRP in postmenopausal women. J Am Coll Cardiol 41 (2003) 1358-1363
10. Parker M.G., Arbuckle N., Dauvois S., Danielian P., and White R. Structure and function of the estrogen receptor. Ann NY Acad Sci 684 (1993) 119-126
11. Kunnas T.A., Laippala P., Penttila A., Lehtimäki T., and Karhunen P.J. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ 321 (2000) 273-274
12. Lehrer S., Rabin J., Kalir T., and Schachter B.S. Estrogen receptor variant and hypertension in women. Hypertension 21 (1993) 439-441
13. Shearman A.M., Cupples L.A., Demissie S., et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290 (2003) 2263-2270
14. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51 (1983) 606
15. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
16. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
17. Knopp R.H. Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am J Obstet Gynecol 158 (1988) 1630-1643
18. Jones D.R., Schmidt R.J., Pickard R.T., Foxworthy P.S., and Eacho P.I. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res 43 (2002) 383-391
19. Lamon-Fava S., Ordovas J.M., and Schaefer E.J. Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 19 (1999) 2960-2965
20. Ma P.T., Yamamoto T., Goldstein J.L., and Brown M.S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. Proc Natl Acad Sci USA 83 (1986) 792-796
21. Almeida S., Fiegenbaum M., de Andrade F.M., Osorio-Wender M.C., and Hutz M.H. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy. Maturitas 54 (2006) 119-126
22. Bagger Y.Z., Hassager C., Heegaard A.M., and Christiansen C. Vitamin D receptor and estrogen receptor gene polymorphisms in postmenopausal Danish women: no relation to bone markers or serum lipoproteins. Climacteric 3 (2000) 84-91
23. Demissie S., Cupples L.A., Shearman A.M., et al. Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis 185 (2006) 210-218
24. Herrington D.M., Howard T.D., Hawkins G.A., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346 (2002) 967-974
25. Nordström P., Glader C.A., Dahlén G., et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 254 (2003) 140-146
26. Silvestri S., Thomsen A.B., Gozzini A., Bagger Y., Christiansen C., and Brandi M.L. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?. Menopause 13 (2006) 451-461
27. Matsubara Y., Murata M., Kawano K., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17 (1997) 3006-3012
28. Kikuchi T., Hashimoto N., Kawasaki T., and Uchiyama M. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr 89 (2000) 42-45
29. Lehtimäki T., Laaksonen R., Mattila K.M., et al. Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men. Eur J Clin Invest 32 (2002) 400-404
30. Huang Q., Wang T.H., Lu W.S., et al. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J 119 (2006) 1794-1801
31. de Maat M.P., Bladbjerg E.M., Kluft C., et al. Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis. Hum Reprod 21 (2006) 1473-1476
32. Jakimiuk A.J., Bogusiewicz M., Skorupski P., et al. Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, CRP and homocysteine in postmenopausal women. Gynecol Endocrinol 23 (2007) 584-589
33. Molvarec A., Nagy B., Kovacs M., et al. Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms. Clin Chim Acta 380 (2007) 157-164